Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
Clinical trial NCT02872103 · COMPLETED
Trial details
- NCT number
- NCT02872103
- Sponsor
- EVIVE Biotechnology
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-12-20
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.